Ifosfamide--pharmacology, safety and therapeutic potential

Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998

Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?

Annals of oncology : official journal of the European Society for Medical Oncology·1993

Dosing and side-effects of ifosfamide plus mesna.

Journal of cancer research and clinical oncology·1991

Reverse hemolytic plaque assay study of luteinizing and follicle-stimulating hormone and thyrotropin secretion in diabetic rat pituitary glands.

Diabetes·1989

[Aortic valvular dysplasia in a dog].

Schweizer Archiv fur Tierheilkunde·1989

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Cancer treatment reviews·2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Cancer treatment reviews·2026

From bench to bedside: experimental pharmacology approaches to overcome bioavailability, stability, and translational barriers of bioactive peptides from natural sources.

Frontiers in pharmacology·2026

Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.

Pharmaceuticals (Basel, Switzerland)·2026

Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2026

Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.

International journal of molecular sciences·2026

Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease.

Biomolecules·2026

From syndrome to precision therapy: current and emerging therapeutic options for selected pediatric focal epilepsies.

Expert opinion on pharmacotherapy·2026

Related Experiment Videos

Ifosfamide--pharmacology, safety and therapeutic potential

Related Concept Videos

Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.

Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide.

Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?

Dosing and side-effects of ifosfamide plus mesna.

Reverse hemolytic plaque assay study of luteinizing and follicle-stimulating hormone and thyrotropin secretion in diabetic rat pituitary glands.

[Aortic valvular dysplasia in a dog].

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

From bench to bedside: experimental pharmacology approaches to overcome bioavailability, stability, and translational barriers of bioactive peptides from natural sources.

Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.

Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.

Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.

Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease.

From syndrome to precision therapy: current and emerging therapeutic options for selected pediatric focal epilepsies.

Related Experiment Videos

Ifosfamide--pharmacology, safety and therapeutic potential

Related Concept Videos

Related Articles